These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 205621)

  • 1. Biochemical characterization of pituitary-dependent hyperadrenocorticism in the dog.
    Meijer JC; de Bruijne JJ; Rijnberk A; Croughs RJ
    J Endocrinol; 1978 Apr; 77(1):111-8. PubMed ID: 205621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness to corticotropin-releasing hormone and vasopressin in canine Cushing's syndrome.
    van Wijk PA; Rijnberk A; Croughs RJ; Wolfswinkel J; Selman PJ; Mol JA
    Eur J Endocrinol; 1994 Apr; 130(4):410-6. PubMed ID: 8162173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine hyperadrenocorticism due to adrenocortical neoplasia. Pretreatment evaluation of 41 dogs.
    Reusch CE; Feldman EC
    J Vet Intern Med; 1991; 5(1):3-10. PubMed ID: 1850483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenocortical function tests in dogs with hyperfunctioning adrenocortical tumours.
    Meijer JC; Lubberink AA; Rijnberk A; Croughs RJ
    J Endocrinol; 1979 Mar; 80(3):315-9. PubMed ID: 438707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ACTH response and dexamethasone suppression as screening tests in canine hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 1983 Mar; 182(5):506-10. PubMed ID: 6300008
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma cortisol response to exogenous ACTH in 22 dogs with hyperadrenocorticism caused by adrenocortical neoplasia.
    Peterson ME; Gilbertson SR; Drucker WD
    J Am Vet Med Assoc; 1982 Mar; 180(5):542-4. PubMed ID: 6277837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary tumor size, neurologic signs, and relation to endocrine test results in dogs with pituitary-dependent hyperadrenocorticism: 43 cases (1980-1990).
    Kipperman BS; Feldman EC; Dybdal NO; Nelson RW
    J Am Vet Med Assoc; 1992 Sep; 201(5):762-7. PubMed ID: 1328121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of hyperadrenocorticism in dogs as compared to human diagnostic methods: a review.
    Thuróczy J; Balogh L; Huszenicza G; Jánoki GA; Kulcsár M
    Acta Vet Hung; 1998; 46(2):157-73. PubMed ID: 9704520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a six-hour combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 1986 Dec; 189(12):1562-6. PubMed ID: 3025143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-dexamethasone-suppressible, pituitary-dependent hyperadrenocorticism in a dog.
    Kemppainen RJ; Zenoble RD
    J Am Vet Med Assoc; 1985 Aug; 187(3):276-8. PubMed ID: 4030467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs.
    Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1996 Aug; 209(4):772-5. PubMed ID: 8756877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperadrenocorticism in a dog due to ectopic secretion of adrenocorticotropic hormone.
    Galac S; Kooistra HS; Voorhout G; van den Ingh TS; Mol JA; van den Berg G; Meij BP
    Domest Anim Endocrinol; 2005 Apr; 28(3):338-48. PubMed ID: 15760674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary corticoid/creatinine ratios in the differentiation between pituitary-dependent hyperadrenocorticism and hyperadrenocorticism due to adrenocortical tumour in the dog.
    Galac S; Kooistra HS; Teske E; Rijnberk A
    Vet Q; 1997 Mar; 19(1):17-20. PubMed ID: 9225424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening tests used in the diagnosis of canine hyperadrenocorticism.
    Mack RE
    Semin Vet Med Surg Small Anim; 1994 Aug; 9(3):118-22. PubMed ID: 7938929
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of a combined dexamethasone suppression/ACTH stimulation test in dogs with hyperadrenocorticism.
    Feldman EC
    J Am Vet Med Assoc; 1985 Jul; 187(1):49-53. PubMed ID: 2991177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of cyproheptadine treatment in dogs with pituitary-dependent hyperadrenocorticism.
    Stolp R; Croughs RJ; Rijnberk A
    J Endocrinol; 1984 Jun; 101(3):311-4. PubMed ID: 6726107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism.
    Mack RE; Feldman EC
    J Am Vet Med Assoc; 1990 Dec; 197(12):1603-6. PubMed ID: 2177458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperadrenocorticism in the dog: canine Cushing's syndrome.
    Owens JM; Drucker WD
    Vet Clin North Am; 1977 Aug; 7(3):583-602. PubMed ID: 198937
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of 17-hydroxyprogesterone in the diagnosis of canine hyperadrenocorticism.
    Ristic JM; Ramsey IK; Heath EM; Evans HJ; Herrtage ME
    J Vet Intern Med; 2002; 16(4):433-9. PubMed ID: 12141305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol binding capacity of corticosteroid binding globulin in hyperadrenocorticoid and healthy dogs.
    Bamberg-Thalén B; Nyberg L; Fackler L; Edqvist LE
    Res Vet Sci; 1992 May; 52(3):363-6. PubMed ID: 1620969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.